Effects of folk medicinal plant extract ankaferd blood stopper® in vital primary molar pulpotomy

European Archives of Paediatric Dentistry

Volumn 13, Issue 4, 2012, Pages 197-202

  Yaman, E ^a   Gorken F ^a   Erdem, A Pinar ^a   Sepet, E ^a   Aytepe, Z ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Ankaferd; Formocresol; Primary molars; Pulpotomy

Indexed keywords

EID: 84867683965     PISSN: 18186300     EISSN: 19969805     Source Type: Journal    
DOI: 10.1007/BF03262870     Document Type: Article

References (30)

1. Alaçam A, Odabaş ME, Tüzüner T, Sillelioǧlu H, Baygin O. Clinical and radiographic outcomes of calcium hydroxide and formocresol pulpotomies performed by dental students. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 108:e127-133.
2. American Academy of Paediatric Dentistry. Guideline on pulp therapy for primary and immature permanent teeth. Reference Manual, revised 2009; 33:212-219.
3. Ansari G, Ranjpour M. Mineral trioxide aggregate and formocresol pulpotomy of primary teeth: 2-year follow-up. International Endodontic Journal 2010; 43:413-418.
4. Bilgili H, Kosar A, Kurt M et al. Haemostatic efficacy of Ankaferd Blood Stop- per (r) in a swine bleeding model. Med Prin Pract 2009; 18:165-169.
5. Croll TP, Killian CM. Zinc oxide-eugenol pulpotomy and stainless steel crown restoration of a primary molar. Quintessence Int 1992; 23:383-388.
6. Erdem AP, Guven Y, Balli B et al. Success rates of mineral trioxide aggregate, ferric sulphate, and formocresol pulpotomies: a 24-month study. Pediatr Dent 2011; 33:546-551.
7. Firat HC, Ozdemir O, Kosar A, Goker H, Haznedaroglu IC. Annual review of Ankaferd 08-09. Naviga publications, Istanbul, 2009, pp.13-19.
8. Fuks AB, Holan G, Davis JM, Eidelman E. Ferric sulphate versus dilute for- mocresol in pulpotomized primary molars: Long-term follow up. Pediatr Dent 1997; 19:327-330.
9. Fuks AB, Papagiannoulis L. Pulpotomy in primary teeth: Review of the litera- ture according to standardized assessment criteria. Eur Arch Paediatr Dent 2006; 7:64-71.
10. Fuks AB. Vital pulp therapy with new materials for primary teeth: New direc- tions and treatment perspectives. J. Endod 2008; 34(7S):S18-24.
11. Goker H, Haznedaroglu IC, Ercetin S et al. Haemostatic actions of the folk- loric medicinal plant extract Ankaferd Blood Stopper®. J Int Med Res 2008; 36:163-170.
12. Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pediatr Dent 2005; 27:129-136.
13. Jabbarifar SE, Khademi AA, Gahsemi D. Success rate of formocresol pul- potomy versus mineral trioxide aggregate in human primary molar tooth. J Res Med Sci 2004; 6:304-307.
14. Kilpatrick NM, Neumann A. Durability of amalgam in the restoration of class II cavities in primary molars: a systematic review of the literature. Eur Arch Paediatr Dent 2007; 8:5-13.
15. Lee SJ, Umano K, Shibamoto T, Lee KG. Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chem 2007; 91:131-137.
16. Lemon RR, Steele PJ, Jeansonne BG. Ferric sulphate haemostasis: Effect on osseous wound healing left in situ for maximum exposure. J Endod 1993; 19:170-173.
17. Matsuda H, Ando S, Kato T, Morikawa T, Yoshikawa M. Inhibitors from the rhizomes of Alpinia officinarum on production of nitric oxide in lipopolysaccharide-activated macrophages and the structural requirements of diarylheptanoids for the activity. Bioorg Med Chem 2006; 14:138-142.
18. Milnes AR. Persuasive evidence that formocresol use in pediatric dentistry is safe. J Can Den Assoc 2006; 72:247-248.
19. Moretti AB, Sakai VT, Oliveira TM et al. The effectiveness of mineral trioxide aggregate, calcium hydroxide, and formocresol for pulpotomies in primary teeth. Int Endod J 2008; 41:547-555.
20. Ng FK, Messer LB. Mineral trioxide aggregate as a pulpotomy medicament: A narrative review. Eur Arch Paediatr Dent 2008; 9:4-11.
21. Ni Chaollai A, Monteiro J, Duggal MS. The teaching of management of the pulp in primary molars in Europe: a preliminary investigation in Ireland and the UK. Eur Arch Paediatr Dent 2009; 10:98-103.
22. Odabaş ME, Cinar C, Tulunoglu O, Isik B. A new haemostatic agent's effect on the success of calciumhydroxide pulpotomy in primary molars. Pediatric Dentistry 2011a; 33:546-551.
23. Odabaş ME, Erturk M, Cinar C, Tuzuner T, Tulunoǧlu O. Cytotoxicity of a new haemostatic agent on human pulp fibroblasts in vitro. Med Oral Patol Oral Cir Bucal 2011b; 16 :e584-587.
24. Olivi G, Genovese MD. Laser reflcetive dentistry in children and adolescents. Eur Arch Paediatr Dent 2011; 12:68-78.
25. Papagiannoulis L. Clinical studies on ferric sulphate as a pulpotomy medica- ment in primary teeth. Eur J Paediatr Dent 2002; 3:126-132.
26. Peng L, Ye L, Tan H, Zhou X. Evaluation of the formocresol vs mineral trioxide aggreagate primary molar pulpotomy: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102:e40-44.
27. Peng L, Ye L, Guo X et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis. In Endod J 2007; 40:751-757.
28. Rodd HD, Boissonade FM. Immunocytochemical investigation of immune cells within human primary and permanent tooth pulp. Int J Paediatr Dent 2006; 16:2-9.
29. Rodd HD, Waterhouse PJ, Fuks AB, Fayle SA, Moffat MA. Pulp therapy for primary molars. UK National Clinical Guidelines in Paediatric Dentistry. Int J Paediatr Dent. 2006; 16:15-23.
30. Sonmez D, Sari S, Cetinbas T. A comparison of four pulpotomy techniques in primary molars: A long-term follow-up. J Endod 2008; 34:950-955